FRI073 Use Of Obesogenic Medications Among Patients With Type 2 Diabetes In The Dominican Republic

Disclosure: S.P. Agramonte Villar: None. C.R. Gil Vega: None. J.M. Reynoso Ortiz: None. L.R. Sosa Pinedo: None. R.A. Vasquez Morel: None. C.M. Polanco Santos: None. V.T. San Martin: None. Background: Obesity is a major risk factor for the development and progression of type 2 diabetes mellitus (T2DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Agramonte Villar, Scarlet P, Gil Vega, Carlos R, Reynoso Ortiz, Jose M, Sosa Pinedo, Lisbeth R, Vasquez Morel, Roberto A, Polanco Santos, Carmen M, San Martin, Vicente T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555711/
http://dx.doi.org/10.1210/jendso/bvad114.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555711/
http://dx.doi.org/10.1210/jendso/bvad114.083

Ejemplares similares